GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Total Tax Payable

JFL Life Sciences (NSE:JFLLIFE) Total Tax Payable : ₹0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Total Tax Payable?

JFL Life Sciences's Total Tax Payable for the quarter that ended in Mar. 2024 was ₹0.0 Mil.


JFL Life Sciences Total Tax Payable Historical Data

The historical data trend for JFL Life Sciences's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Total Tax Payable Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Tax Payable
Get a 7-Day Free Trial - - - - -

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Tax Payable Get a 7-Day Free Trial - - - - -

JFL Life Sciences Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


JFL Life Sciences Total Tax Payable Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines